19-55368855-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000264563.7(IL11):āc.94T>Gā(p.Ser32Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,583,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000264563.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL11 | NM_000641.4 | c.94T>G | p.Ser32Ala | missense_variant | 2/5 | ENST00000264563.7 | NP_000632.1 | |
IL11 | NM_001267718.2 | c.-57-286T>G | intron_variant | NP_001254647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL11 | ENST00000264563.7 | c.94T>G | p.Ser32Ala | missense_variant | 2/5 | 1 | NM_000641.4 | ENSP00000264563.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000266 AC: 52AN: 195654Hom.: 0 AF XY: 0.000257 AC XY: 27AN XY: 105218
GnomAD4 exome AF: 0.000130 AC: 186AN: 1431054Hom.: 0 Cov.: 32 AF XY: 0.000143 AC XY: 101AN XY: 708554
GnomAD4 genome AF: 0.000118 AC: 18AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74264
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.94T>G (p.S32A) alteration is located in exon 2 (coding exon 2) of the IL11 gene. This alteration results from a T to G substitution at nucleotide position 94, causing the serine (S) at amino acid position 32 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at